Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Shionogi

Rare Disease news

Rare Diseases Today—March 26, 2026

This week’s Rare Diseases update highlights regulatory designations, new…

Rare Disease news

Rare Disease Today—January 8, 2026

This rare disease update covers major regulatory approvals, strategic…

Respiratory

Respiratory Weekly News - July 4th 2025

Lung & Respiratory Breakthroughs: ALYFTREK Approval, IPF Trial Milestones,…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Cell and Gene Therapy Today—March 26, 2026
Rare Diseases Today—March 26, 2026
Cardiovascular Today—March 26, 2026
Lucid Diligence Brief: MSD to acquire Terns
Neuroscience Today—March 25, 2026

Tags

Ada Health AI ethics British Heart Foundation Chronic disease mortality conduction-system pacing cost reduction DIPS Arena Endogenex Enzalutamide FDA Digital Health Advisory FG001 GLP-1 Receptor Agonists gout flares Hemab Therapeutics hyperphosphatemia Imcivree Jaypirca JUST-AAV licensing Limb-Girdle Muscular Dystrophy Type R5 live biotherapeutic product MAV/06 MicroRNAs naxtarubicin NovaBridge OCALIVA Palvella Therapeutics PPMS Rare Disease Diagnosis Rinvoq Rituximab Romeck Pharma seralutinib Spikevax Stanford Medicine Sutra Medical TG Therapeutics Therna Biosciences trained immunity Transgene TYMLOS Uncontrolled Hypertension UNFPA Ver-A-T1D weight loss durability

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Cell and Gene Therapy Today—March 26, 2026
Rare Diseases Today—March 26, 2026
Cardiovascular Today—March 26, 2026
Lucid Diligence Brief: MSD to acquire Terns
Neuroscience Today—March 25, 2026

TAGS

Ada Health AI ethics British Heart Foundation Chronic disease mortality conduction-system pacing cost reduction DIPS Arena Endogenex Enzalutamide FDA Digital Health Advisory FG001 GLP-1 Receptor Agonists gout flares Hemab Therapeutics hyperphosphatemia Imcivree Jaypirca JUST-AAV licensing Limb-Girdle Muscular Dystrophy Type R5 live biotherapeutic product MAV/06 MicroRNAs naxtarubicin NovaBridge OCALIVA Palvella Therapeutics PPMS Rare Disease Diagnosis Rinvoq Rituximab Romeck Pharma seralutinib Spikevax Stanford Medicine Sutra Medical TG Therapeutics Therna Biosciences trained immunity Transgene TYMLOS Uncontrolled Hypertension UNFPA Ver-A-T1D weight loss durability

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy